Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer

Completed · Not applicable

Conditions studied: Radiation Fibrosis

In brief

RATIONALE: Pirfenidone may prevent or lessen fibrosis caused by radiation therapy. PURPOSE: Pilot trial to study the effectiveness of pirfenidone in preventing or lessening fibrosis in patients who have undergone radiation therapy for cancer.

Key facts

Study ID

NCT00020631

Run by

National Cancer Institute (NCI)

Starts

2001-10-01

Expected to finish

2007-10-01

Last updated by the study team

2013-06-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.